Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: SAINT-TAVR Calcium Registry
Recruiting now
Conditions studied: Aortic Stenosis
In brief
The goal of this observational study is to learn about the long-term effects of aortic valve annular calcification in patients undergoing transcatheter aortic valve replacement (TAVR). The main question it aims to answer is: Does the degree of aortic valve annular calcification prior to TAVR influence long-term clinical outcomes, including major adverse cardiovascular events including all-cause mortality, over a 3-year period? Participants who have undergone TAVR as part of their regular medical care for severe aortic stenosis will have their pre-procedural imaging and clinical outcomes evaluated for a 3-year follow-up period.
Key facts
- Study ID
- NCT06722066
- Run by
- Eunpyeong St. Mary's Hospital
- People needed
- 500
- Starts
- 2024-10-02
- Expected to finish
- 2034-10-02
- Last updated by the study team
- 2024-12-09
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 19 years or older.
- Patients who have undergone transcatheter aortic valve replacement (TAVR) for severe aortic stenosis.
- Individuals who have voluntarily provided written informed consent to participate.
You may not qualify if…
- Individuals who have not provided written informed consent for this study.
Where it is running
- Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.